Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-16

Clinical Trial Update: Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing levosimendan alone versus levosimendan with magnesium sulfate for spine protection assessed by NIRS in infants undergoing coarctectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)
  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Dalia Saad Abd-El Kader | Conditions: Aortic Coarctation | Phase 4 | Status: COMPLETED